Kefah Mokbel
Overview
Explore the profile of Kefah Mokbel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
196
Citations
2130
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mokbel R, Kodresko A, Mokbel K, Ghazal H, Trembley J, Jouhara H
In Vivo
. 2025 Feb;
39(2):577-612.
PMID: 40010951
Skin and subcutaneous diseases represent a significant public health burden, profoundly impacting quality of life, social interactions, mental health, and daily activities-raising concerns worldwide. In modern cryogenics, cryosurgery is among...
2.
ONeill N, Rizk M, Li A, Martin T, Jiang W, Mokbel K
Cancer Genomics Proteomics
. 2025 Feb;
22(2):231-246.
PMID: 39993803
Background/aim: The disialoganglioside GD2 has been shown to promote cell proliferation, migration, tumor and metastasis through specific signaling pathways in tumor cells originating from the neuroectoderm, including melanomas, neuroblastomas, glioblastomas,...
3.
4.
5.
6.
7.
Rizk M, Mokbel K
Breast Cancer Res Treat
. 2024 Nov;
209(2):451-452.
PMID: 39528739
No abstract available.
8.
Mokbel K
Cancer Genomics Proteomics
. 2024 Oct;
21(6):549-556.
PMID: 39467630
Expression of disialoganglioside GD2 in normal tissues is primarily limited to the central nervous system, peripheral sensory nerve fibers, dermal melanocytes, lymphocytes, and mesenchymal stem cells. Its widespread overexpression in...
9.
Al-Shamsi H, Abdelwahed N, Mokbel K
J Clin Oncol
. 2024 Oct;
43(1):109-111.
PMID: 39361902
No abstract available.
10.
Mokbel K, Kodresko A, Trembley J, Jouhara H
J Clin Med
. 2024 Sep;
13(18).
PMID: 39336884
Alopecia is a common adverse effect of neoadjuvant or adjuvant chemotherapy in patients with early breast cancer. While hair typically regrows over time, more than 40% of patients continue to...